Jundishapur Journal of Microbiology

Published by: Kowsar

Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli

Rana Rahmani 1 , Gholamreza Zarrini 1 , * , Farzam Sheikhzadeh 2 and Naser Aghamohammadzadeh 3
Authors Information
1 Laboratory of Microbiology, Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, IR Iran
2 Department of Animal Sciences, Faculty of Natural Sciences, University of Tabriz, Tabriz, IR Iran
3 Department of Medicine, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: February 2015, 8 (2); e59808
  • Published Online: February 20, 2015
  • Article Type: Research Article
  • Received: January 20, 2014
  • Revised: May 3, 2014
  • Accepted: May 14, 2014
  • DOI: 10.5812/jjm.17744

To Cite: Rahmani R, Zarrini G, Sheikhzadeh F, Aghamohammadzadeh N. Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli, Jundishapur J Microbiol. 2015 ;8(2):e59808. doi: 10.5812/jjm.17744.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sulakvelidze A. The challenges of bacteriophage therapy. Eur Ind Pharm. 2011; 10: 14-8
  • 2. Abhilash M, Vidya A, Jagadevi T. Bacteriophage therapy: A war against antibiotic resistant bacteria. Internet J Altern Med. 2009; 7(1)
  • 3. Ghannad MS, Mohammadi A. Bacteriophage: time to re-evaluate the potential of phage therapy as a promising agent to control multidrug-resistant bacteria. Iran J Basic Med Sci. 2012; 15(2): 693
  • 4. Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009; 18(6): 237-8[DOI][PubMed]
  • 5. Alexander SK, Strete D, Niles MJ. Laboratory exercises in organismal and molecular microbiology. 2004;
  • 6. Pattee PA. Use of tetrazolium for improved resolution of bacteriophage plaques. J Bacteriol. 1966; 92(3): 787-8[PubMed]
  • 7. Momoh ARM, Orhue PO, Idonije OB, Oaikhena AG, Nwoke EO, Momoh AA. The antibiogram types of Escherichia coli isolated from suspected urinary tract infection samples. J Microbiol Biotech Res. 2011; 1(3): 57-65
  • 8. Mubita C, Syakalima M, Chisenga C, Munyeme M, Bwalya M, Chifumpa G, et al. Antibiograms of faecal Escherichia coli and Enterococci species isolated from pastoralist cattle in the interface areas of the Kafue basin in Zambia. Vet Arh. 2008; 78(2): 179
  • 9. Thaker H, Brahmbhatt M, Nayak J. Study on occurrence and antibiogram pattern of Escherichia coli from raw milk samples in Anand, Gujarat, India. Vet World. 2012; 5(9): 556[DOI]
  • 10. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol. 1982; 128(2): 307-18[PubMed]
  • 11. Smith HW, Huggins MB, Shaw KM. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol. 1987; 133(5): 1111-26[PubMed]
  • 12. Barrow P, Lovell M, Berchieri A Jr. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol. 1998; 5(3): 294-8[PubMed]
  • 13. Jamalludeen N, Johnson RP, Shewen PE, Gyles CL. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs. Vet Microbiol. 2009; 136(1-2): 135-41[DOI][PubMed]
  • 14. Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, et al. A method for generation phage cocktail with great therapeutic potential. PLoS One. 2012; 7(3)[DOI][PubMed]
  • 15. Bruttin A, Brussow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005; 49(7): 2874-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments